Skip to main content
logo
Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
38.60
+0.99 (2.63%)
At close: Sep 4, 2026, 4:00 PM EDT
38.12
-0.48 (-1.24%)
After-hours: Sep 4, 2026, 7:30 PM EDT

Neurogene Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--0.93---
Revenue Growth
------
Cost of Revenue
88.3874.8960.8344.3947.5142.26
Gross Profit
-88.38-74.89-59.9-44.39-47.51-42.26
Selling, General & Admin
32.8528.3222.6111.199.018.27
Operating Expenses
32.8528.3222.6111.199.018.27
Operating Income
-121.23-103.21-82.51-55.58-56.52-50.53
Interest Expense
-0-0.01-0.01-0.01-0-
Interest & Investment Income
9.7211.558.472.951.340.02
Other Non Operating Income (Expenses)
0.521.44-0.99-0.03-0.01-
EBT Excluding Unusual Items
-110.99-90.23-75.05-52.67-55.19-50.52
Asset Writedown
-0.12-0.12-0.09---
Other Unusual Items
---16.36--
Pretax Income
-111.11-90.35-75.14-36.32-55.19-50.52
Net Income
-111.11-90.35-75.14-36.32-55.19-50.52
Preferred Dividends & Other Adjustments
----49.97--
Net Income to Common
-111.11-90.35-75.1413.65-55.19-50.52
Net Income Growth
------
Shares Outstanding (Basic)
222118004
Shares Outstanding (Diluted)
222118504
Shares Change
12.28%21.40%277.22%1080.37%-90.26%-
EPS (Basic)
-5.04-4.24-4.2827.76-139.88-12.47
EPS (Diluted)
-5.04-4.24-4.282.93-139.88-12.47
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-87.71-78.36-71.41-51.74-55.05-64.77
Free Cash Flow Per Share
-3.98-3.67-4.07-11.11-139.54-15.99
Operating Margin
---8920.43%---
Profit Margin
---8123.68%---
Free Cash Flow Margin
---7720.11%---
EBITDA
-117.99-100.12-79.27-52.29-53.32-49.59
D&A For EBITDA
3.243.093.253.33.20.95
EBIT
-121.23-103.21-82.51-55.58-56.52-50.53
SEC Filings: 10-K · 10-Q